Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice

Author: Dziennis Suzan  

Publisher: Springer Publishing Company

ISSN: 0885-7490

Source: Metabolic Brain Disease, Vol.26, Iss.2, 2011-06, pp. : 123-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content